The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

Leukemia. 2020 Oct;34(10):2815-2816. doi: 10.1038/s41375-020-01038-8. Epub 2020 Sep 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Janus Kinase 1
  • Nitriles
  • Pandemics*
  • Pneumonia, Viral*
  • Protein Kinase Inhibitors*
  • Pyrazoles
  • Pyrimidines
  • SARS-CoV-2

Substances

  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • Janus Kinase 1